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Background: A recently published meta-analysis comparing metallic staples to sutures in orthopaedic procedures
revealed three fold increase in risk for infection in stapled wounds. The studies included in the meta-analysis are at
risk of bias due to experimental design limitations. A large randomized controlled trial is proposed to direct
orthopaedic surgeons in their choice of wound closure material.
Methods/Design: A parallel group randomized controlled trial with institutional review board approval will be
conducted. Patients will be randomized intraoperatively to have skin wounds closed with sutures or staples.
Dressings will be used to maintain blinding outcome assessors. The primary outcome measure will be a composite
all-cause wound complication outcome measure composed of: infection, wound drainage, wound necrosis,
blistering, dehiscence, suture abscess and material sensitivity reaction. An independent review board blinded to
treatment assignment will adjudicate suspected complications based on clinical data. All deceased patients will also
be reviewed. An interim analysis of complications will take place after half of the patients have been recruited. All
data will be analyzed by a blinded statistician. Dichotomous primary and secondary outcome measures will be
analyzed using the Chi-squared statistic. Continuous outcome measures will be analyzed using Student's t-test.
Subgroup analysis will compare infection rates using sutures versus staples in each anatomic area (upper extremity,
pelvis/acetabulum, hip/femur, knee, ankle). A further subgroup analysis will be conducted comparing trauma
patients to elective surgery patients. Non-infected revision surgery will also be compared to primary surgery.
Discussion: Wound closure material is an afterthought for many orthopaedic surgeons. The combined results of
several comparative trials suggests that the choice of wound closure materials may have an impact on the rate of
surgical site infections. However, the strength of the evidence is poor given the heterogeneity of the methods
employed in previous studies. The following study protocol aims to guide surgeons in their choice of wound
closure material by determining if there is a difference in complication rates in sutured and stapled wounds.
Trial Registration: This trial was registered at ClinicalTrials.gov under the identifier NCT01146236 (registered June
14, 2010)
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Surgical site infections
The Centers for Disease Control (CDC) defines surgical
site infections (SSIs) as superficial incisional, deep inci-
sional and organ/space infections based on clinical and
laboratory confirmation [1]. Two-hundred and ninety-
thousand SSIs occur in the United States annually fol-
lowing elective orthopaedic surgery resulting in $1 bil-
lion to $10 billion in additional healthcare costs
according to CDC estimates from 2001. Many of these
infections require long-term intravenous antibiotic treat-
ment or further surgical interventions. It has been esti-
mated that SSIs lead to a $4,500 per case (in 1990
dollars) increase in health care costs in the United States
[2]. Some estimates have found that surgical site infec-
tions in hip and knee replacement can incur an add-
itional cost in excess of $28,000 [3].
Skin closure efficacy
Animal studies have shown the mechanical equivalence
of stapled and sutured wounds [4]. Clinical studies in
several specialties have not shown superiority of the cos-
metic appearance of stapled or sutured wounds [5,6].
These authors also found that patient satisfaction with
the two methods of wound closure was not significantly
different. In practice, it is uncommon for a patient to re-
ceive the choice of closure method pre-operatively and it
is also rare to find patients with absolute preferences to
one closure material over another.
Skin closure cost-effectiveness
Several studies have mentioned the time saved in insert-
ing and removing staples when compared with sutures
[5,7]. These studies rely on the calculation of the time
saved by employing metallic staples compared to the
cost of the staple insertion device. Singh et al. (2006)
have previously published that staples are more than
eight times more costly to insert and remove than are
sutures [8]. No study has factored the cost of complica-
tions into a cost analysis comparing sutures and metallic
staples.
No comparative trial exists that has the statistical
power to determine if the rate of infection in wounds
closed with staples is different from that in wounds
closed with sutures in orthopaedic procedures. A study
in cardiac procedures suggested that subcuticular sutur-
ing in sternal wounds led to a lower overall rate of com-
plications than stapling [9]. Although the results of a
recent meta-analysis [10] suggest that the use of staples
in hip and knee surgery should be questioned, the
included studies [7,8,11-14] did not uniformly employ
experimental designs that limit bias. There is also a pau-
city of data to guide surgeons working in various ana-
tomic locations on the type of wound closure materialthat confers the lowest risk of infection. A large, rando-
mized and blinded prospective trial is needed to provide
an answer to the question of what material is best for
the closure of clean surgical wounds.
Research question
In adult patients undergoing orthopaedic procedures
does the wound closure material (sutures versus metallic
staples) influence the occurrence of post-operative
wound complications within the first year?
Objectives
 To determine the best surgical skin wound closure
material for use in various orthopaedic surgical
procedures from a patient safety perspective.
 To identify procedures in which staple or suture
closure results in an increased risk of wound
complications.
 To determine if surgical wounds in trauma patients
require different closure material than elective
surgical wounds at distinct anatomic sites.
Hypotheses
It is hypothesized that wounds closed with sutures and
staples will have similar all-cause complication rates.
The alternative hypothesis is that these wound closure
methods result in different rates of complications indi-
cating that one method is superior to the other and
should be utilized for the tested procedures.
Methods
Study approval
This protocol was approved by the local institutional re-
view board in May 2010. Participation is purely voluntary
and withdrawal from the study after randomization will be
allowed. The study was also registered at clinicaltrials.gov
after institutional review board approval. Registration
identification NCT01146236 (registered June 14, 2010)
Study sample
The study will be executed in five medical centers
affiliated with two accredited universities. Patients will be
drawn from a catchment of 2.7 million inhabitants. The
study population will be a mix of rural and urban patients
from diverse ethnic backgrounds. A variety of procedures
will be included in the study encompassing both urgent
and elective operations.
Trial design
Parallel Group Randomized Controlled Trial with Economic
Analysis
Recruitment of patients under the care of subspecialists
in Orthopaedic Trauma, Spine, Adult Reconstruction
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currently with the same trial infrastructure. Patients will
be recruited by the office assistant, research assistant or
delegate of the treating surgeon administering the surgi-
cal consent form. Verbal consent will be obtained for
trauma patients unable to sign a consent form. Written
consent will be obtained within 24 hours of treatment
allocation. Patients eligible but not enrolled will be
documented. Participant flow through the study can be
seen visually in Figure 1.
Inclusion criteria
 Adult patients (> 18 years old)
 All open orthopaedic procedures
 Any wound> 2 cm in lengthAdult Orthopedic Patients
Undergoing an Operative
Procedure
• Adult patients (>18 years old)
• All open orthopaedic procedures
• Largest wound >2cm in length
Intraoperative Randomization
Skin Closure with Sutures
Method (Subcuticular or Interrupted)




Review of all suspected complications by blinded, independent com
Cases Determined by Self-reported occurrence of complicati
Figure 1 Participant flow diagram representing the planned design oExclusion criteria
 Open fracture
 Known nickel allergy
 Active infection (any site)
 Foot surgery (any site)
 Hand surgery (including carpal surgery)
 Arthroscopic procedures
Interventions
 Skin closure with metallic staples
 Skin closure with suture material – type of suture
(non-absorbable or absorbable) and technique
(simple, horizontal mattress, vertical mattress,
subcuticular) at the discretion of the surgeon.• Open fracture
• Known nickel allergy
• Active infection (any site)
• Foot surgery (any site)
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Randomization will be concealed and will be allo-
cated at the time of skin closure. Randomization will
be completed using an online randomization pro-
gram. Block randomization with randomly sized
blocks between eight and 12 participants will be
employed to ensure an equal number of participants
in each group for each subspecialty. Group assign-
ments will be revealed by the online randomization
program and the time of the randomization will be
recorded electronically. Times of randomization will
be compared with operative notes retrospectively to
ensure concealment is being maintained.
Methods of blinding
Blinding of patients and providers was attempted in a pilot
study. It was found that it was not feasible to blind these
groups to the treatment allocation after post-operative
dressings were changed, generally at postoperative day
two. Additionally, post-operative radiographs revealed
stapled patients in the pilot, further unblinding both pro-
viders and participants.
Outcome assessors will be blinded to the closure
method through the use of long sleeved shirts, pants
or a sleeve provided for the patient to wear. Blinding
will be maintained by trained clinic staff aware of
the purpose and methods of blinding. Participants
will be asked not to reveal randomization when they
become aware of treatment allocation during the
course of the follow-up.
The outcomes adjudication committee will be blinded
to treatment group during the determination of compli-
cations of individual patients. The data analysis team will
also be blinded to the treatment groups during the syn-
thesis of the results which will be presented as Group A
and Group B in the draft manuscript.
Primary outcome measure
The primary outcome measure will be a composite out-
come encompassing all causes of wound complication.
The clinical relevance of the primary outcome measure
stems from the fact that the components of the compos-
ite outcome all represent occurrences that are patient
important. The components consist of the following
events:
1. Surgical site infection as defined by: Use of intravenous antibiotics
 Use of oral antibiotics
 Re-operation at same site
2. Wound drainage occurring after post-operative day
two requiring a dressing change.3. Wound Necrosis defined as blackening of the skin
edges at the incision site or skin slough observed by
providers or the participant.
4. Suture Abscess defined as the expulsion of deep
suture material and purulent material without
surrounding erythema.
5. Peri-incision Blistering defined as blistering at the
edge of the incision along the entire length.
Blistering at dressing tape site will be excluded from
this definition, however, blistering due to wound
tape application which is contiguous with the wound
edge will be considered an event.
6. Wound Dehiscence as defined by the loss of
apposition of the skin edges visible to the eye along
the length of the incision.
7. Material Sensitivity as defined by a local reaction to
metal or suture material resulting in skin changes
along the entire incision length.
The primary outcome measure will be assessed during
admission by review of the patient chart by site coordi-
nators who will be blinded to the treatment allocation.
Outcome assessors will be uniformly trained in the defi-
nitions of the components of the composite outcome
score. Outpatient complications will be recorded
through self-report questionnaires administered by site
coordinators. All deceased patients will also be reviewed
for occurrence wound complications. Final determin-
ation of events will be made by an independent out-
comes adjudication committee based on blinded clinical
data identified by the committee as necessary for the de-
termination of complications. A sample of non-infected
participants will also be reviewed by the committee as a
negative control.
Secondary outcome measures
Treatment preference reported by the participant
Additional unscheduled episodes of care as defined by:
Dressing changes by homecare/patient at home or self-
reported visits to other healthcare professionals.
Length-of-stay – Based on admission and discharge
dates
Visual analogue pain score for suture/staple removal
Justification of the length of follow-up
The occurrence of SSIs happens primarily in the first
three months post-operatively. The Centers for Disease
Control (CDC) defines the timing of SSI as within the
first 30 days unless a foreign body is implanted. In the
presence of an implanted foreign body the surveillance
period is extended to one year. Since the majority of
orthopaedic surgeries result in the implantation of a me-
tallic body we have extended the follow-up period to
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ure is a composite measure related to the healing of a
wound we will analyze the data after all participants have
completed six-week follow-up. A phone survey will be
performed at one year in order to conform with the
CDC definition of SSI.Sample size determination
Estimates of sample size necessary to definitively test the
hypothesis in this study were calculated using rates of
wound complications found in a pilot study which
included 148 participants. A relative risk reduction of
25% in wound complications was chosen as a minimal
clinically important difference in wound complications.
Sample sizes are presented graphically for varying
powers and with a constant α level of 0.05 (Figure 2).
Microsoft Excel (Redmond, WA) was utilized to perform
calculations. The details of the sample size calculation
are presented in Figure 2.Anticipated recruitment rate
In a pilot site it was found that 60% of patients
approached consented to participate. A recruitment
model was created taking into account expected site fa-
tigue and differences in consenting efficiency between
the United States and Canada. Based on the combined
clinical volume at the five sites it is expected that the
study will be completed with enrolment after 24 months
























Figure 2 Projected sample size based on a relative risk reduction of 2currently being developed to ensure that this target is
met and to improve the generalizability of the results.
Data analysis
All anatomic sites will be analyzed together and separ-
ately using Stata (College Station, TX). Dichotomous pri-
mary and secondary outcome measures will be analyzed
using Fisher’s exact test. Stratification based on potential
confounding variables will be performed. A multivariable
analysis employing logistic regression will be performed
to assess the possible impact of empirical confounding
by putative risk factors of the binary outcomes. Length
of stay, visual analogue scale pain measurements and pa-
tient satisfaction data will be compared using a two-way
ANOVA. Linear regression will be performed on con-
tinuous variables to assess the possible impact of empir-
ical confounding by putative risk factors. A 4.7% level of
significance will be considered significant based on the
adjustment of significance level for the interim analysis.
Subgroup analyses will be performed comparing the
use of sutures and staples in trauma versus elective pro-
cedures and primary versus revision procedures as
appropriate.
Interim analysis
Interim analysis will be performed by a Data Safety and
Monitoring Committee blinded to the treatment groups.
Analyses will take place at the half-way point of patient
recruitment. The alpha spending function approach to





5% for wound complications and using an alpha of 0.05.
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using a significance level of 0.15% based on the O’Brien-
Flemming boundaries for a group sequential trial.
Discussion
Patient-centered outcomes
The importance of patient-centered outcomes is becom-
ing more recognized in medicine. In orthopaedic sur-
gery, the increasing popularity of patient-driven rather
than surgeon-driven functional outcomes reflects this
general trend. Little information exists on the incidence
of patient-perceived wound complications in ortho-
paedic surgery. Based on the bias encountered in
surgeon-measured outcomes there is a possibility that
the current literature reflects an underestimate of the
frequency of wound complications as a result of current
definitions of these events and standard ways of deter-
mining their occurrence. This study additionally aims to
find a true rate of patient-perceived wound complica-
tions to allow surgeons to better inform patients of sur-
gical risks.
Clinical relevance
The inclusion of both community and tertiary centers
will help to make the results of this trial immediately ap-
plicable for surgeons in diverse areas of practice. Given
the inclusion of both trauma and elective patients and as
a result of the powering of the study for each anatomic
location, the results will also inform practitioners if there
is a difference in the rate of complications as a result of
wound closure material at those individual sites. The
results will reflect the realities of practice in both a
teaching and community environment.
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